EN
HI
Summary
As of 11 Oct, 2026, Symbiotec Pharmalab stock price is ₹1087.5. During the trading session, the stock has moved between an intraday low of ₹1078.10 and an intraday high of ₹1112.50. Over the last 52 weeks, Symbiotec Pharmalab has traded between ₹934.20 and ₹1246.00.
The stock has recorded a trading volume of 4,02,278 shares,. Its Average Traded Price (ATP) is ₹1091.91, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 10 @ ₹1087.50.
Symbiotec Pharmalab has an upper circuit limit of ₹1305.00 and a lower circuit limit of ₹870.00. The total value traded stands at ₹43.93 CR, and the delivery percentage for the day is 37.45%.
The stock is currently traded with a market lot size of 1. Symbiotec Pharmalab also offers a dividend yield of 0%.
Symbiotec Pharmalab Share Price Chart
Symbiotec Pharmalab Share Key Metrics
Volume
4.02 L
Market Cap
6987.85 CR
LTQ@LTP
10@1087.50
ATP
1091.91
Var Margin
12.5 %
Circuit Range
870-1305
Delivery %
37.45 %
Value
43.93 CR
ASM/GSM
No
Market Lot
1
Symbiotec Pharmalab Fundamentals
P/E Ratio
63.6
P/B Ratio
4.66
Div. Yield
0
Sector P/E
41.33
Sector P/B
3.47
Sec. Div. Yield
0.53
Symbiotec Pharmalab Resistance and Support
Pivot 1105.83
Resistance
First Resistance
1130.96
Second Resistance
1168.13
Third Resistance
1193.26
Support
First Support
1068.66
Second Support
1043.53
Third Support
1006.36
Symbiotec Pharmalab Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Oct 09 2026 | 1081 | 1087.5 | -0.58% | 1112.5 | 1078.1 |
| Thu Oct 08 2026 | 1130 | 1093.8 | -3.68% | 1143 | 1080.69 |
| Wed Oct 07 2026 | 1149.4 | 1135.59 | -1.21% | 1165 | 1122.19 |
Symbiotec Pharmalab Corporate Actions
| Date | Agenda |
|---|---|
| 2026-09-21 | Quarterly Results |
Symbiotec Pharmalab News
Symbiotec Pharmalab Ltd - 544889 - Symbiotec''s Wholly Owned Subsidiary Knovea Pharmaceutical Enters Into Strategic Commercialization Agreement With A Leading Global Pharmaceutical Company For Dual Chamber Vial Products In The U.S.
Symbiotec Pharmalab's subsidiary Knovea Pharmaceutical has entered an exclusive commercialization agreement with a leading global pharma company. The partner will distribute two Dual Chamber Vial injectable products in the US market, which is estimated at $288 million.
Sep 30 2026 20:09:23
Symbiotec Pharmalab Ltd - 544889 - Announcement Under Regulation 30 (LODR)-Symbiotec Pharmalab Limited Receives Establishment Inspection Report ("EIR") From U.S. FDA For Its Manufacturing Facility In Pithampur ('SEZ') With VAI Classification
Symbiotec Pharmalab has received the Establishment Inspection Report (EIR) from the US FDA for its manufacturing facility in Pithampur, Madhya Pradesh. The facility was classified under Voluntary Action Indicated (VAI) status, following an inspection conducted in August 2026.
Sep 29 2026 10:52:27
Read More
Symbiotec Pharmalab Management
| Name | Position |
|---|---|
| Anil Satwani | Chairman & Managing Director |
| Hariharnath Buggana | Nominee Director |
Symbiotec Pharmalab Similar Stocks
Aarti Pharmalabs Ltd.
855.50
-23.55 (2.68%)
Suven Life Sciences Ltd.
282.75
-6.15 (2.13%)
Jupiter Life Line Hospitals Ltd.
255.70
8.60 (3.48%)
Thyrocare Technologies Ltd.
499.70
-1.30 (0.26%)
Morepen Laboratories Ltd.
129.55
-7.00 (5.13%)
Bliss GVS Pharma Ltd.
655.95
-11.75 (1.76%)
Sanofi India Ltd.
2945.40
-34.30 (1.15%)
Innova Captab Ltd.
1110.00
-19.50 (1.73%)
Kovai Medical Center & Hospital Ltd.
5876.00
-15.50 (0.26%)
IOL Chemicals And Pharmaceuticals Ltd.
201.15
-4.40 (2.14%)
Symbiotec Pharmalab FAQs
The Buying Price of Symbiotec Pharmalab share is 1087.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Symbiotec Pharmalab stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Symbiotec Pharmalab, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Symbiotec Pharmalab shares is 63.6. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Symbiotec Pharmalab shares is 4.66. Useful to assess the stock's value relative to its book value.
To assess Symbiotec Pharmalab’s valuation compare Sector P/E, P/B which are 41.33 & 3.47 with sector averages, along with growth rates and financial metrics.
The Market Cap of Symbiotec Pharmalab is 6987.85 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Symbiotec Pharmalab share price is 1246.00 & 934.20. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Symbiotec Pharmalab belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in SYMBIOTEC
